Bronchiolitis and Wheezing

Published on 06/06/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2679 times

37 Bronchiolitis and Wheezing

Wheezing is a high-pitched musical sound produced by air flowing through narrowed airways. Wheezes are heard mostly during the expiratory phase. They are usually a sign of increased airway resistance resulting from obstruction in the intrathoracic airways. The predominance of wheezing during expiration is explained by the normal tendency of the intrathoracic airways to narrow when the intrapleural pressure exceeds intraluminal pressure during this phase of respiration. Narrowing of the intrathoracic airways is accentuated when the expiratory intrapleural pressure becomes positive during forced exhalation or in the setting of small airways obstruction. When obstruction occurs in the extrathoracic airways, it manifests with a distinct harsh inspiratory noise that is referred to as stridor.

Wheezing is heterophonous or polyphonic in nature when there is diffuse narrowing of the airways. This widespread involvement of the airways produces a mixture of sounds associated with various degrees of obstruction to airflow. Multiple varied degrees of obstruction typically occur in the presence of bronchospasm, edema, or intraluminal secretions. The most common causes of heterophonous wheezing in the pediatric population are viral bronchiolitis and asthma (see Chapter 38). Conversely, homophonous wheezing refers to a single set of pitches that originates in the larger airways but that can be transmitted widely. Common causes of homophonous wheezing include tracheomalacia, bronchomalacia, foreign body aspiration, and anatomic compression of the airways (Figure 37-1).

Etiology and Pathogenesis

The majority of wheezing in infants is caused by viral bronchiolitis or asthma, but many other entities can also cause wheezing at this age (Box 37-1).

Bronchiolitis

Bronchiolitis commonly refers to an acute episode of obstructive lower airway disease caused by a viral infection in infants younger than 24 months of age. The peak incidence of severe disease occurs between 2 and 6 months of age. Approximately 1% of infants in the first 12 months of life are hospitalized with bronchiolitis, accounting for more than 125,000 annual hospitalizations in the United States. Hospitalization rates are five times higher in high-risk groups, including premature infants with bronchopulmonary dysplasia and patients with congenital heart disease.

The infectious cause of acute bronchiolitis typically includes viruses with specific tropism for bronchiolar epithelium. Respiratory syncytial virus (RSV) is responsible for more than 50% of cases, but other viruses are increasingly recognized as causes of this clinical entity. Viral infection of the lower airways can induce severe changes in the epithelial cell and mucosal surfaces of the human respiratory tract. Bronchiolar epithelial cell necrosis, ciliary disruption, and peribronchiolar lymphocytic infiltration are the earliest lesions. Edema of the small airways and mucus secretion, mixed with denudated epithelial cells, elicits obstruction and narrowing of the airways (see Figure 37-2). The generation of atelectasis is often associated with ventilation/perfusion mismatch and consequent hypoxemia. Heterogeneous ventilation and dynamic collapse of the airways during exhalation can lead to air trapping and pulmonary hyperinflation (see Figure 37-2). With severe obstructive lung disease and respiratory muscle fatigue, hypercapnia can also arise.

Many infants with RSV infection do not develop bronchiolitis. Approximately 60% to 70% of RSV-infected infants will have disease confined to the upper respiratory tract. The severity of the clinical syndrome is largely determined by host immunologic and anatomic factors. The presence of immunoglobulin G antibodies to the F (fusion) protein of RSV (whether transplacentally acquired or administered postnatally) attenuates the severity of the RSV infection. Conversely, premature infants are particularly prone to developing significant lower respiratory symptoms. The lungs of newborns with bronchopulmonary dysplasia have alveolar simplification and thus decreased small airways diameter because of lower elastic recoil. Because airflow resistance is inversely related to the radius of the airway to the fourth power, airflow in infants with bronchopulmonary dysplasia can be compromised with minimal changes in the bronchiolar lumen. Bronchiolitis is also more common in boys, in those who have not been breastfed, and in those who live in crowded conditions.

Asthma

Asthma is another important cause of wheezing in infants and children (see Chapter 38). This clinical entity is characterized by recurrent episodes of airway obstruction that are at least partially reversible with bronchodilators. Another pathogenic feature of the disease is chronic inflammation of the airways. Whereas extensive bronchiolar epithelial cell necrosis and T-helper cell type 1 (Th1) cytokines like interferon-γ are present in viral bronchiolitis, inflammation in asthma is often driven by allergic (Th2) cytokines such as interleukin-13 (IL-13), IL-4, and IL-5. Other abnormalities of the asthmatic airway include constriction and hypertrophy of the airway smooth muscle, mucosal edema, hypertrophic mucous glands, and sometimes eosinophilic infiltration.

Viral infections are the most common causes of exacerbations in infantile asthma. As opposed to bronchiolitis, lower respiratory symptoms in asthma tend to recur during exposure to other triggers, such as exercise, allergens, or cold air. Depending on the clinical course of their wheezing, infants may be early transient wheezers with at least one episode before the age of 3 years but complete resolution by school age; persistent wheezers with episodes before 3 years that are still present at 6 years of age; or late-onset wheezers with no history of wheezing by 3 years but with wheezing by 6 years. Approximately 60% of infants who wheeze will outgrow wheezing by 6 years of age. Risk factors for persistent wheezing include a maternal history of asthma, maternal smoking, elevated immunoglobulin E (IgE) level, and eczema at younger than 1 year of age. In addition, early respiratory viral infections, particularly RSV and rhinovirus, are associated with the presence of subsequent recurrent wheezing and asthma.

Whether bronchiolitis modifies the immune response or airway biology to evoke asthma later in life is still unclear. Experimental studies primarily based on animal models have reported that early RSV infection can upregulate neurokinin-mediated neurogenic inflammation, potentially leading to airway hyperreactivity. Other proasthmatic mechanisms postulated include a viral-induced bias of the host toward allergic Th2 immune responses during early infancy and the production of virus-specific IgE antibodies. Notwithstanding these hypotheses, infants with bronchiolitis may be a select group of patients with an inherent predisposition to asthma that is simply unmasked by an episode of viral respiratory infection. The relationship between early respiratory viral infections and subsequent wheezing and asthma remains a topic of intense investigation and controversy.

Clinical Presentation

When evaluating an infant with an acute respiratory illness a critical question to answer is whether or not there is involvement of the lower airways. In RSV infection, non-specific upper respiratory tract symptoms consisting of nasal discharge and mild cough begin about 3 to 5 days after exposure. The progression of the disease to the lower respiratory tract is characterized by the presence of tachypnea, hypoxemia, nasal flaring and intercostal or subcostal retractions. The typical course for a previously healthy infant older than 6 months is one of improvement over the subsequent 2 to 5 days. Significant hypoxemia, grunting and marked use of accessory muscles are signs of severe disease and impending respiratory failure (Figure 37-3). Central apnea can also be an early manifestation of RSV infection, at times also resulting in respiratory failure.

Viral bronchiolitis is one of several syndromes associated with obstruction of the intrathoracic small airways; thus, the presence of expiratory heterophonous wheezing is a common but non-specific sign of the disease. Wheezing in infants can be better appreciated on pulmonary auscultation when elicited by gentle chest compression (so-called “squeeze the wheeze”) to induce forced expiratory flow. A marked reduction in amplitude of breathing sounds suggests very severe disease with nearly complete bronchiolar obstruction. Auscultation in bronchiolitis may also reveal inspiratory crackles as small airways re-open, and prolongation of the expiratory phase. The other cardinal feature of small airways obstruction is pulmonary hyperinflation. This clinical feature helps to localize the disease in the small airways as it is a manifestation of alveolar air trapping. The key signs of hyperinflation are an increase in antero-posterior diameter of the chest wall, the presence of subcostal retractions and the palpation of a normal sized liver below the costal margin (see Figure 37-3).

Given that early respiratory viral infections are associated with the presence of recurrent wheezing and asthma, the initial differentiation between these entities is often difficult. Many infants originally diagnosed with viral bronchiolitis are later categorized as asthmatics. In the asthmatic child, the presence of intermittent symptoms such as coughing or wheezing at night or in response to exercise, crying, laughing, mist, or cold air can facilitate the diagnosis. Adequate responses to bronchodilator therapy and typically also to corticosteroids are characteristic features of asthma as well. An atopic phenotype (i.e., eczema or elevated IgE levels) and a positive family history of asthma also point toward the diagnosis of this disease.

The clinical evaluation of wheezing should also include a detailed feeding history. Respiratory symptoms such as cough, cyanosis, or respiratory distress during feeds suggest laryngeal penetration or pulmonary aspiration. Given that aspiration can also be “silent,” especially at night, early morning symptoms may be the only clue for the diagnosis. Aspiration of gastric contents or direct penetration of oral liquids during feeding is particularly common in children with neurodevelopmental abnormalities or anatomic defects of the respiratory system such as tracheoesophageal fistula (TEF) or laryngeal cleft.

When wheezing is persistent and nonresponsive to therapy, the consideration of uncommon but serious medical conditions such as CF, PCD, and immunodeficiency is in order. As opposed to asthma, these diseases are often associated with failure to thrive. This is particularly true in patients with CF because of the presence of malabsorption caused by pancreatic insufficiency. Digital clubbing may be present in patients with CF, PCD, and other causes of bronchiectasis but should never be present in uncomplicated asthma. Recurrent sinusitis and bacterial bronchitis are common features of CF, PCD, and some immunodeficiencies. PCD invariably causes significant abnormalities of the middle ear and is often associated with situs inversus or abdominal heterotaxy. Tachypnea during the neonatal period and persistent purulent rhinorrhea during infancy are also typical features of this disease.

The presence of homophonous wheezing is suggestive of abnormalities in the large rather than the small intrathoracic airways. Tracheal collapse secondary to highly compliant airways can produce homophonous wheezing in infants. This condition, termed tracheomalacia, seldom affects respiratory function at rest (infants are often referred to as “happy wheezers”), and isolated congenital tracheomalacia usually resolves after 1 year of age. Nevertheless, infants with significant collapse of the central airways during the expulsive phase of cough, particularly those with congenital or acquired tracheal abnormalities (e.g., TEF), can have inadequate clearance of airway secretions. A harsh “barking” cough is a key clinical sign present in this situation. These patients often have a protracted clinical course accompanied by recurrent lower tract infections and frequent hospital visits.

Congenital malformations cause homophonous wheezing in early infancy when they externally compress the airway or cause intrinsic obstruction of the airway lumen. Vascular rings secondary to abnormal development of the aortic arch can produce considerable constriction of the subjacent trachea (see Figure 37-1). Virtually any type of congenital intrathoracic lesion, depending on its size and location, can potentially cause external compression of the airways. Other causes of external compression include mediastinal lymphadenopathy secondary to infections (e.g., tuberculosis) or malignancies (e.g., lymphoma) (see Figure 37-1). Intrinsic obstruction of the airway lumen may be caused by foreign body aspiration, hemangiomas, and rarely carcinoid tumors (see Figure 37-1). Airway hemangiomas should be suspected particularly when they are present in other areas of the body (e.g., skin).

Evaluation and Management

The diagnosis of bronchiolitis is essentially clinical but can be supported by radiographic findings. Typical chest radiographic findings are hyperinflation, increased peribronchial markings, and patchy subsegmental atelectasis. The absence of cystic lesions, pleural effusions, and focal densities suggestive of bacterial infection are other valuable pieces of information obtained from the chest radiograph. Rapid viral detection tests (i.e., immunofluorescence or polymerase chain reaction) are helpful if the diagnosis is uncertain or for epidemiologic purposes.

The management of patients with bronchiolitis largely depends on the severity of the disease. Most infants can be managed at home with supportive care, but hypoxemia or inability to feed adequately requires hospitalization. After an infant is hospitalized, supportive care is the mainstay of therapy and involves appropriate fluid replacement and the use of supplemental oxygen when necessary. Routine use of bronchodilators and corticosteroids is not indicated unless there is a component of airway hyperreactivity or a formal diagnosis of asthma. Severe cases of bronchiolitis may need the initiation of noninvasive ventilation techniques to deliver continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BLPAP) and sometimes endotracheal intubation to provide invasive mechanical ventilatory support.

Several other interventions may be helpful in refractory cases. Pulmonary aspiration is a common complication in infants with bronchiolitis caused by tachypnea and respiratory distress. Enteral feeds via nasogastric tube may be indicated to prevent ongoing lung damage and allow recovery from the acute illness. Nebulized hypertonic saline to facilitate the mobilization of tenacious airway secretions and racemic epinephrine to decrease airway mucosal edema have shown positive results in some clinical trials, but their routine use is not currently recommended. Other small studies have also suggested that exogenous surfactant, helium and oxygen mixtures (heliox), and combination therapies (i.e., corticosteroids and epinephrine and bronchodilators) can offer clinical benefit in some cases. Ribavirin is a nucleoside analogue with in vitro activity against RSV and other viruses, but its usefulness is controversial, and it is rarely used in clinical practice.

In addition to the care of the acute episode, prevention is another important consideration in the management of viral bronchiolitis. Meticulous hand washing is the best measure to prevent the transmission of RSV and most other respiratory viruses. Monthly administration of monoclonal anti-F antibody (palivizumab) throughout the RSV season has become standard of care for infants at high risk for developing severe respiratory illnesses secondary to RSV infection. In general, palivizumab is recommended for infants younger than 6 to 12 months of age born prematurely or those younger than 2 years of age with bronchopulmonary dysplasia or other significant comorbidities, including immunodeficiency, chronic lung disease, and cyanotic congenital heart conditions. Secondhand tobacco smoke is associated with an increased incidence of respiratory infections in infants and young children, so parents should be counseled to avoid exposing their children to this irritant.

Many children develop multiple wheezing illnesses during infancy secondary to viral bronchiolitis or asthma; however, a poor response to therapy, complicated courses, and a nonreassuring clinical evaluation (e.g., failure to thrive) are indications for further evaluation. A sweat test to evaluate for CF and assessment of baseline immune status are simple tests that can rule out serious underlying conditions. Careful clinical observation after administration of a bronchodilator aerosol is often all that is required to demonstrate the presence of bronchospasm and bronchodilator responsiveness. Pulmonary function testing, available for infants at some specialized centers, can also evaluate bronchodilator responsiveness and inform about the degree and location of the obstruction. If there is concern about aspiration, a swallowing study and evaluation for GER should be considered. In addition, visualization of the gastrointestinal (GI) and respiratory tract may be necessary to exclude congenital abnormalities such as laryngeal cleft or TEF. Depending on the clinical suspicion, contrast upper GI studies, laryngoscopy, bronchoscopy, or GI endoscopy may be indicated.

If there is no clear clinical evidence of tracheomalacia, the existence of homophonous wheezing often requires direct visualization of the respiratory system by bronchoscopy to exclude fixed obstruction or foreign body aspiration. This is particularly true when the sound is located in just one area of the chest or when it is present during inspiration and expiration (biphasic wheezing). A chest radiograph provides valuable information about the presence of mediastinal adenopathy, masses, and other space-occupying lesions. Because vascular rings are often associated with a right aortic arch, the chest radiograph can also be used to confirm the normal location of the aortic arch on the left side. Upper GI series can also inform about potential extrinsic vascular compressions of the trachea. If indicated, magnetic resonance imaging or computed tomography (CT) angiography are best to delineate vascular lesions of the chest. Chest CT scan is sometimes necessary to further evaluate the anatomy or to rule out extrinsic obstruction of the airways. The diagnosis of other less common causes of wheezing such as PCD often requires more sophisticated testing. These evaluations may include biopsies of the respiratory tract or genetic-molecular analysis and are indicated only in select cases with high index of clinical suspicion.